WebPhysicians’ perspectives on the treatment of osteoporosis patients with bisphosphonates Tao Gu,1 Debra F Eisenberg Lawrence,1 Judith J Stephenson,1 Jingbo Yu2 1HealthCore, Wilmington, DE, 2Merck & Co., Inc., Kenilworth, NJ, USA Background: Noncompliance with bisphosphonate therapy among osteoporosis patients attenuates the reduction of … WebThis meta-analysis indicated that zoledronic acid could significantly reduce the fracture risk and increase BMD in postmenopausal women with osteoporosis. Furthermore, it would not result in serious adverse events. Zoledronic acid could be used as an effective and well-tolerated treatment for postmenopausal women with osteoporosis.
Which medication should I take? - Royal Osteoporosis Society
WebDec 13, 2024 · If you have a cancer diagnosis and have at least one other risk factor for osteoporosis, you will likely be asked to take a bone mineral density test. For cases in which your oncologist has prescribed an anti-cancer medication known to cause bone loss, this test should be repeated at least every two years, if not sooner. WebThe word ‘osteoporosis’ means ‘porous bone.’. It is a disease that weakens bones, and if you have it, you are at a greater risk for sudden and unexpected bone fractures. Osteoporosis … pregnancy insurance india
Osteoporosis - ScienceDirect
WebJan 26, 2024 · Summary. Fractures resulting from osteoporosis become increasingly common in women after age 55 years and men after age 65 years, resulting in substantial bone-associated morbidities, and increased mortality and health-care costs. Research advances have led to a more accurate assessment of fracture risk and have increased the … WebDec 21, 2024 · Pharmacologic options also include anabolic agents to promote bone formation in higher-risk patients with osteoporosis; ... be instructed to take 1000 mg of calcium daily and at least 400 IU of vitamin D daily ... considerations with bisphosphonates for the treatment of osteoporosis. Drug Saf. 2007. 30(9):755-63 ... WebJul 21, 2024 · In the absence of specific contraindications, oral bisphosphonates are considered initial pharmacologic therapy for most patients at high risk for fracture. We prefer oral bisphosphonates as initial therapy because of their efficacy, favorable cost, and the availability of long-term safety data. (See "Overview of the management of … pregnancy internal hemorrhoids